SNDX - Syndax Pharmaceuticals Inc. (SNDX) CEO Dr. Briggs Morrison on Q1 2021 Results - Earnings Call Transcript
Syndax Pharmaceuticals, Inc. (SNDX) Q1 2021 Results Earnings Conference Call May 11, 2021, 04:30 PM ET Company Participants Melissa Forst - Argot Partners Dr. Briggs Morrison - Chief Executive Officer Daphne Karydas - Chief Financial Officer Michael Metzger - President, Chief Operating Officer Dr. Michael Meyers - Chief Medical Officer Dr. Peter Ordentlich - Chief Scientific Officer Conference Call Participants Philip Nadeau - Cowen & Company Bert Hazlett - BTIG Colleen Kusy - Baird Peter Lawson - Barclays Justin Walsh - B. Riley Securities David Lebowitz - Morgan Stanley Presentation Operator Ladies and gentlemen, thank you for standing by and welcome to the Syndax First Quarter 2021 Earnings Conference Call. At this time all participants are in a listen-only mode. After the speaker’s presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded. [Operator Instructions] I would now like to hand the
For further details see:
Syndax Pharmaceuticals, Inc. (SNDX) CEO Dr. Briggs Morrison on Q1 2021 Results - Earnings Call Transcript